Sponsor or institution
Clinical trials and research at Cometa Therapeutics INC
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $1.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Gene therapy approach to GSD-1b with a novel G6PT1 promoter-driven AAV vector
A new gene therapy approach aims to restore normal blood sugar in people with Glycogen Storage Disease type 1b by delivering the G6PT1 gene using an AAV vector.
-
A new gene therapy for Glycogen Storage Disease 1b
This study is testing a new gene therapy to help people with Glycogen Storage Disease 1b (GSD-Ib) by using a special delivery method to improve their blood sugar control and overall health.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.